Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Kobayashi, 2004, Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy, Gastric Cancer, 7, 233, 10.1007/s10120-004-0297-0 Alberts, 2003, Gastric cancer: epidemiology, pathology and treatment, Ann Oncol, 14, 31, 10.1093/annonc/mdg726 Jemal, 2007, Cancer statistics, 2007, CA Cancer J Clin, 57, 43, 10.3322/canjclin.57.1.43 Vogiatzi, 2007, Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis, J Cell Physiol, 211, 287, 10.1002/jcp.20982 Yasui, 2003, Histone acetylation and gastrointestinal carcinogenesis, Ann NY Acad Sci, 983, 220, 10.1111/j.1749-6632.2003.tb05977.x Yoo, 2006, Epigenetic therapy of cancer: past, present and future, Nat Rev Drug Discov, 5, 37, 10.1038/nrd1930 Minucci, 2006, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer, Nat Rev Cancer, 6, 38, 10.1038/nrc1779 Drummond, 2005, Clinical development of histone deacetylase inhibitors as anticancer agents, Annu Rev Pharmacol Toxicol, 45, 495, 10.1146/annurev.pharmtox.45.120403.095825 Marks, 2007, Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug, Nat Biotechnol, 25, 84, 10.1038/nbt1272 Suzuki, 2000, Effect of trichostatin A on cell growth and expression of cell cycle- and apoptosis-related molecules in human gastric and oral carcinoma cell lines, Int J Cancer, 88, 992, 10.1002/1097-0215(20001215)88:6<992::AID-IJC24>3.0.CO;2-9 Park, 2004, Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation, Clin Cancer Res, 10, 5271, 10.1158/1078-0432.CCR-03-0709 Huang, 2007, Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment, Biochem Pharmacol, 73, 990, 10.1016/j.bcp.2006.12.013 Xu, 2007, Histone deacetylase inhibitors: molecular mechanisms of action, Oncogene, 26, 5541, 10.1038/sj.onc.1210620 Bolden, 2006, Anticancer activities of histone deacetylase inhibitors, Nat Rev Drug Discov, 5, 769, 10.1038/nrd2133 Zhang, 2004, Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells, Int J Cancer, 110, 301, 10.1002/ijc.20117 Adachi, 2004, Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells, Clin Cancer Res, 10, 3853, 10.1158/1078-0432.CCR-03-0806 Feng, 2006, Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression, Cancer Res, 66, 8762, 10.1158/0008-5472.CAN-06-1006 Laurén, 1965, The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma, Acta Pathol Microbiol Scand, 64, 31, 10.1111/apm.1965.64.1.31 Noske, 2007, Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer, Cancer Lett, 246, 190, 10.1016/j.canlet.2006.02.018 Weichert, 2007, High expression of RelA/p65 is associated with activation of nuclear factor-κB dependent signaling in pancreatic cancer and marks a patient population with poor prognosis, Br J Cancer, 97, 523, 10.1038/sj.bjc.6603878 Munster, 2001, The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells, Cancer Res, 61, 8492 Heerdt, 1994, Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines, Cancer Res, 54, 3288 Song, 2005, Increased expression of histone deacetylase 2 is found in human gastric cancer, APMIS, 113, 264, 10.1111/j.1600-0463.2005.apm_04.x Kim, 2004, Downregulation of gelsolin and retinoic acid receptor beta expression in gastric cancer tissues through histone deacetylase 1, J Gastroenterol Hepatol, 19, 218, 10.1111/j.1440-1746.2004.03336.x Lee, 2003, Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE, Genomics, 82, 78, 10.1016/S0888-7543(03)00098-3 Ono, 2002, Acetylated histone H4 is reduced in human gastric adenomas and carcinomas, J Exp Clin Cancer Res, 21, 377 Zhu, 2004, Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis, Cancer Cell, 5, 455, 10.1016/S1535-6108(04)00114-X Rephaeli, 2005, In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer, Int J Cancer, 116, 226, 10.1002/ijc.21030 Yasui, 2005, Molecular-pathological prognostic factors of gastric cancer: a review, Gastric Cancer, 8, 86, 10.1007/s10120-005-0320-0